Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2144)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2025 (publication date) through Aug 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiong SX, Huang LJ, Liu HS, Zhang XX, Li M, Cui YB, Shao C, Hu XL. Dapagliflozin exerts anti-apoptotic effects by mitigating macrophage polarization via modulation of the phosphoinositide 3-kinase/protein kinase B signaling pathway. World J Diabetes 2025; 16(2): 97287 [PMID: 39959262 DOI: 10.4239/wjd.v16.i2.97287] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i2/97287.htm |
| Number | Citing Articles |
| 1 |
Amin Ullah, Bairong Shen. Immunomodulatory effects of anti-diabetic therapies: Cytokine and chemokine modulation by metformin, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists (2013–2025). European Journal of Medicinal Chemistry 2025; 299: 118065 doi: 10.1016/j.ejmech.2025.118065
|